Veterinary Medicines

Nobilis RT+IBmulti+ND+EDS emulsion for injection for chickens

Authorised
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Eggdrop syndrome-1976 virus, strain BC14, Inactivated
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
  • Avian infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis RT+IBmulti+ND+EDS emulsion for injection for chickens
Nobilis RT+IBmulti+ND+EDS emulsija injekcijām vistām
Active substance:
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Eggdrop syndrome-1976 virus, strain BC14, Inactivated
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
  • Avian infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Newcastle disease virus, strain Clone 30, Inactivated
    50.00
    50% Protective Dose
    /
    0.50
    millilitre(s)
  • Eggdrop syndrome-1976 virus, strain BC14, Inactivated
    6.50
    log2 haemagglutination inhibiting unit(s)
    /
    0.50
    millilitre(s)
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
    9.50
    log2 enzyme-linked immunosorbent assay unit(s)
    /
    0.50
    millilitre(s)
  • Avian infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
    4.00
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    5.50
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA18
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/MRP/15/0010
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0209/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • France
  • Greece
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 9/08/2022
Download

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 26/09/2024
Download